-
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
-
2025-521514-26-00
5
2026-01-26
Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer W
-
2024-512486-14-00
5
2026-01-22
Short Bowel Syndrome
-
2025-520766-22-00
5
2026-01-21
Myotonic Dystrophy Type 1
-
2024-520097-36-00
5
2026-01-07
Chronic inflammatory demyelinating polyneuropathy (CIDP)
-
2025-522052-13-00
10
2025-12-24
Framework for Optimizing, Refining, and Unifying Management of HSCT in
-
2023-507525-42-00
5
2025-12-23
Endometrial cancer
-
2024-518899-31-00
5
2025-12-19
Variant or wild-type transthyretin (TTR) amyloid cardiomyopathy
-
2025-521299-76-00
7
2025-12-18
Relapsed or refractory acute leukaemia or Myelodysplastic Syndromes wi
-
2024-517667-23-00
4
2025-12-17
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
-
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-
-
2024-516906-47-00
10
2025-11-28
Locally Advanced or Metastatic Urothelial Carcinoma
-
2025-521707-48-00
1
2025-11-26
KRAS Altered Advanced or Metastatic Solid Tumors
-
2024-512922-27-00
4
2025-11-25
Mantle Cell Lymphoma (MCL)
-
2025-520623-24-00
7
2025-11-19
MTAP-deleted Solid Tumors
-
2024-518006-40-00
5
2025-11-13
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD)
-
2023-508056-19-00
5
2025-10-02
HER2-Expressing (IHC 3+/IHC 2+), Mismatch Repair Proficient (pMMR), P
-
2024-519496-26-00
10
2025-09-25
Intestinal Failure
-
2024-520209-38-00
5
2025-09-19
Obesity or Overweight
-
2025-521234-28-00
5
2025-09-10
Infertility, diminished ovarian reserve.
-
2022-501867-42-01
9
2025-09-08
Acute Lymphoblastic Leukemia, in Relapse
Lymphoblastic Lymphoma (Precu
-
2022-501866-22-00
9
2025-08-26
Acute Lymphoblastic Leukemia, in Relapse
Lymphoblastic Lymphoma (Precu
-
2024-518589-29-00
5
2025-08-21
Bronchiectasis
-
2024-520202-19-00
4
2025-08-19
Subjects with Intestinal Failure-Associated Liver Disease (IFALD)